Skip to content

SystemCHANGE™ Intervention on Medication Adherence in Older Adults With Heart Failure

Impact of SystemCHANGE™ Intervention on Medication Adherence in Older Adults With Heart Failure: A Pilot RCT

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03162848
Acronym
ECHO
Enrollment
2
Registered
2017-05-22
Start date
2017-09-01
Completion date
2018-04-30
Last updated
2019-05-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aging, Heart Failure, Medication Adherence

Brief summary

The purpose of this pilot RCT study is to evaluate the acceptability and feasibility of a SystemCHANGE™ intervention to improve medication adherence in older adults with heart failure. The intervention focuses on changing the individual's environment by incorporating medication taking into existing routines using small experiments with feedback, and receiving support from people who impact routines.

Interventions

BEHAVIORALSystemCHANGE

At initial home visit, the PI will work with the participant to identify important people for medication taking, routines, and cycles of routines. Possible solutions to incorporate medication taking into routines will be identified by the participant and PI and the participant will start implementing these solutions. Medication adherence will continuously be monitored using medication event monitoring systems. At one month, the participant will be sent a report on medication taking and a phone call will occur with the PI to discuss if solutions improved medication adherence or if other solutions need to be implemented. At month two, the intervention will end but participants are urged to continue to use solutions long term.

Sponsors

University of Missouri, Kansas City
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
50 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* age 50 years or older * HF diagnosis confirmed by their physician utilizing their most recent ejection fraction * prescribed diuretics * self-administering medications * able to open an electronic cap * able to speak, hear and understand English * not hospitalized, * no cognitive impairment as determined by a score of 4 or greater on the 6-item mini-mental status exam.

Design outcomes

Primary

MeasureTime frameDescription
Acceptability and feasibility using open ended questionnaireone point in time at the end of the maintenance phase which is 3 months after randomization into groupsopen ended questionnaire asking participants about acceptability and feasibility

Secondary

MeasureTime frameDescription
Systems thinking using questionnairebaseline and after 2 month intervention phasequestionnaire asking about personal systems behavior perceptions
Kansas City Cardiomyopathy Questionnairebaseline and after 2 month intervention phaseheart failure outcomes - SOB, fatigue, swelling, activity tolerance
Medication adherence using medication event monitoring systemsafter randomization through end of maintenance phase for a total of 3 monthsMedication event monitoring systems

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026